Recent Posts

1. 

   Women’s health

   it’s a pretty slow start compared to HQ expectations. We launched a “me too” drug and are making the best of it.There is opportunity to be had but it’s nothing spectacular clinically compared to its competition in the market. Formulary is an...

   Organon

   anonymous

   Apr 16, 2024 at 9:32 AM

2. 

   Amneal

   Are you saying HK and KCS DONT know what is going on? They absolutely know what’s going on. HK is the one who told RBMs to put reps and RBMs on Plans. She does not care about how it affects them. She is an evil ignorant individual.

   Impax Labs/Global

   anonymous

   Apr 16, 2024 at 9:31 AM

3. 

   ImmunityBio

   Heard the launch is not going to happen after all. People starting to leave left and right.

   Syneos Health

   anonymous

   Apr 16, 2024 at 9:30 AM

4. 

   Lay off in CV for jardiance

   It’ll happen end of year. By the point resp gone, Cyltezo gone, CRM and SAE downsized. Year of transformation.

   Boehringer Ingelheim

   anonymous

   Apr 16, 2024 at 9:26 AM

5. 

   Sotyktu floundering

   Seems like everyone is defeated at POA. I do think we can absolutely turn this around.

   Bristol-Myers Squibb

   anonymous

   Apr 16, 2024 at 9:21 AM

6. 

   "One" 2025

   Find another job. You must have limited ability, lazy and lack confidence to stay in such a dreaded place.

   Novartis

   anonymous

   Apr 16, 2024 at 9:21 AM

7. 

   karuna deal

   you do seem like a sloppy seconds kinda guy

   Bristol-Myers Squibb

   anonymous

   Apr 16, 2024 at 9:14 AM

8. + Show More